RE-BVS – Piemonte Repository

Sfoglia per AUTORE
HUBER K
Collezione AOU Novara

Items : 16

Reclassification, Thromboembolic, and Major Bleeding Outcomes Using Different Estimates of Renal Function in Anticoagulated Patients With Atrial Fibrillation: Insights From the PREFER-in-AF and PREFER-in-AF Prolongation Registries. in Circulation. Cardiovascular quality and outcomes / Circ Cardiovasc Qual Outcomes. 2021 Jun;14(6):e006852. doi: 10.1161/CIRCOUTCOMES.120.006852. Epub 20

2021
AOU Novara

Rohla M; Pecen L; Cemin R; Patti G; Siller-Matula JM; Schnabel RB; Huber K; Kirchhof P; De Caterina R;

Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA). in Cardiovascular research / Cardiovasc Res. 2021 Dec 17;117(14):2705-2729. doi: 10.1093/cvr/cvab298.

2021
AOU Novara

Cenko E; Badimon L; Bugiardini R; Claeys MJ; De Luca G; de Wit C; Derumeaux G; Dorobantu M; Duncker DJ; Eringa EC; Gorog DA; Hassager C; Heinzel FR; Huber K; Manfrini O; Milicic D; Oikonomou E; Padro T; Trifunovic-Zamaklar D; Vasiljevic-Pokrajcic Z; Vavlukis M; Vilahur G; Tousoulis D;

Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry. in Internal and emergency medicine / Intern Emerg Med. 2021 Apr;16(3):591-599. doi: 10.1007/s11739-020-02442-9. Epub 2020 Sep 21.

2021
AOU Novara

Darius H; Zamorano JL; Brüggenjürgen B; Verheugt FWA; Huber K; Lucerna M; Rohla M; Sellal JM; Wachter R; Schnabel RB; Siller-Matula JM; Kotecha D; Ricci F; Patti G; Pecen L; Renda G; Duytschaever M; Le Heuzey JY; Schilling RJ; Kirchhof P; De Caterina R;

Thromboembolic and bleeding risk in obese patients with atrial fibrillation according to different anticoagulation strategies. in International journal of cardiology / Int J Cardiol. 2020 Nov 1;318:67-73. doi: 10.1016/j.ijcard.2020.06.010. Epub 2020 Jun 21.

2020
AOU Novara

Patti G; Pecen L; Manu MC; Huber K; Rohla M; Renda G; Siller-Matula J; Ricci F; Kirchhof P; Caterina R;

Impact of time from symptom onset to drug administration on outcome in patients undergoing glycoprotein IIb-IIIa facilitated primary angioplasty (from the EGYPT cooperation). in The American journal of cardiology / Am J Cardiol. 2015 Mar 15;115(6):711-5. doi: 10.1016/j.amjcard.2014.12.030. Epub 2015 Jan 6.

2015
AOU Novara

De Luca G; Van't Hof AW; Gibson CM; Cutlip D; Zeymer U; Noc M; Maioli M; Zorman S; Gabriel HM; Emre A; Rakowski T; Gyongyosi M; Huber K; Bellandi F; Dudek D;

Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors. in Heart and vessels / Heart Vessels. 2014 Jan;29(1):15-20. doi: 10.1007/s00380-013-0323-4. Epub 2013 Mar 14.

2014
AOU Novara

De Luca G; van't Hof AW; Huber K; Gibson CM; Bellandi F; Arntz HR; Maioli M; Noc M; Zorman S; Secco GG; Zeymer U; Gabriel HM; Emre A; Cutlip D; Rakowski T; Gyongyosi M; Dudek D;

Impact of hypertension on distal embolization, myocardial perfusion, and mortality in patients with ST segment elevation myocardial infarction undergoing primary angioplasty. in The American journal of cardiology / Am J Cardiol. 2013 Oct 15;112(8):1083-6. doi: 10.1016/j.amjcard.2013.05.053. Epub 2013 Aug 1.

2013
AOU Novara

De Luca G; van't Hof AW; Huber K; Gibson CM; Bellandi F; Arntz HR; Maioli M; Noc M; Zorman S; Zeymer U; Gabriel HM; Emre A; Cutlip D; Rakowski T; Gyongyosi M; Dudek D;

Impact of time-to-treatment on myocardial perfusion after primary percutaneous coronary intervention with Gp IIb-IIIa inhibitors. in Journal of cardiovascular medicine (Hagerstown, Md.) / J Cardiovasc Med (Hagerstown). 2013 Nov;14(11):815-20. doi: 10.2459/JCM.0b013e32835fcb38.

2013
AOU Novara

De Luca G; Gibson MC; Hof AW; Cutlip D; Zeymer U; Noc M; Maioli M; Zorman S; Gabriel MH; Secco GG; Emre A; Dudek D; Rakowski T; Gyongyosi M; Huber K; Bellandi F;

Impact of multivessel disease on myocardial perfusion and survival among patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitors. in Archives of cardiovascular diseases / Arch Cardiovasc Dis. 2013 Mar;106(3):155-61. doi: 10.1016/j.acvd.2012.12.007. Epub 2013 Apr 2.

2013
AOU Novara

De Luca G; Gibson M; Cutlip D; Huber K; Dudek D; Bellandi F; Noc M; Maioli M; Zorman S; Zeymer U; Secco GG; Mesquita Gabriel H; Emre A; Arntz HR; Rakowski T; Gyongyosi M; Hof AW;

Time-related impact of distal embolisation on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation. in EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology / EuroIntervention. 2012 Aug;8(4):470-6. doi: 10.4244/EIJV8I4A74.

2012
AOU Novara

De Luca G; Gibson CM; Huber K; Dudek D; Cutlip D; Zeymer U; Gyöngyösi M; Bellandi F; Noc M; Arntz HR; Maioli M; Secco GG; Zorman S; Gabriel HM; Emre A; Rakowski T; Van't Hof AW;

Early glycoprotein IIb-IIIa inhibitors in primary angioplasty-abciximab long-term results (EGYPT-ALT) cooperation: individual patient's data meta-analysis. in Journal of thrombosis and haemostasis : JTH / J Thromb Haemost. 2011 Dec;9(12):2361-70. doi: 10.1111/j.1538-7836.2011.04513.x.

2011
AOU Novara

DE Luca G; Bellandi F; Huber K; Noc M; Petronio AS; Arntz HR; Maioli M; Gabriel HM; Zorman S; DE Carlo M; Rakowski T; Gyongyosi M; Dudek D;

Gender-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation. in Journal of thrombosis and thrombolysis / J Thromb Thrombolysis. 2010 Oct;30(3):342-6. doi: 10.1007/s11239-010-0451-y.

2010
AOU Novara

De Luca G; Gibson CM; Gyöngyösi M; Zeymer U; Dudek D; Arntz HR; Bellandi F; Maioli M; Noc M; Zorman S; Gabriel HM; Emre A; Cutlip D; Rakowski T; Huber K; van't Hof AW;

Impact of distal embolization on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation. in Journal of thrombosis and thrombolysis / J Thromb Thrombolysis. 2010 Jul;30(1):23-8. doi: 10.1007/s11239-009-0419-y.

2010
AOU Novara

De Luca G; Gibson CM; Bellandi F; Noc M; Maioli M; Zorman S; Zeymer U; Gabriel HM; Emre A; Cutlip D; Arntz HR; Dudek D; Rakowski T; Gyongyosi M; Huber K; van't Hof AW;

Association between advanced Killip class at presentation and impaired myocardial perfusion among patients with ST-segment elevation myocardial infarction treated with primary angioplasty and adjunctive glycoprotein IIb-IIIa inhibitors. in American heart journal / Am Heart J. 2009 Sep;158(3):416-21. doi: 10.1016/j.ahj.2009.06.029.

2009
AOU Novara

De Luca G; Gibson CM; Huber K; Zeymer U; Dudek D; Cutlip D; Bellandi F; Noc M; Emre A; Zorman S; Gabriel HM; Maioli M; Rakowski T; Gyöngyösi M; Van't Hof AW;

Diabetes mellitus is associated with distal embolization, impaired myocardial perfusion, and higher mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty and glycoprotein IIb-IIIa inhibitors. in Atherosclerosis / Atherosclerosis. 2009 Nov;207(1):181-5. doi: 10.1016/j.atherosclerosis.2009.03.042. Epub 2009 Apr 5.

2009
AOU Novara

De Luca G; Gibson CM; Bellandi F; Noc M; Dudek D; Zeymer U; Arntz HR; Cutlip D; Maioli M; Zorman S; Mesquita Gabriel H; Emre A; Rakowski T; Gyongyosi M; Huber K; Van't Hof AW;

Early glycoprotein IIb-IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis. in Heart (British Cardiac Society) / Heart. 2008 Dec;94(12):1548-58. doi: 10.1136/hrt.2008.141648. Epub 2008 May 12.

2008
AOU Novara

De Luca G; Gibson CM; Bellandi F; Murphy S; Maioli M; Noc M; Zeymer U; Dudek D; Arntz HR; Zorman S; Gabriel HM; Emre A; Cutlip D; Biondi-Zoccai G; Rakowski T; Gyongyosi M; Marino P; Huber K; van't Hof AW;